S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

WVE Wave Life Sciences Ltd

5.67

0.74 (15.01%)

After Hours

Last Updated: 15:32:30

Delayed by 15 minutes

Dosing underway in Wave Life Sciences' mid-stage WVE-004 study in neurodegenerative diseases

To read the full story on Seeking Alpha, click here.

Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Wave Life Sciences Charts.

Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Wave Life Sciences Charts.

Wave Life Sciences Ltd News

Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)
Tuesday 30 April 2024 (1 day ago) • GlobeNewswire Inc.

Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing
Tuesday 23 April 2024 (1 week ago) • GlobeNewswire Inc.

Wave Life Sciences to Present at Upcoming Investor Conferences
Wednesday 27 March 2024 (1 month ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Wednesday 6 March 2024 (2 months ago) • GlobeNewswire Inc.

Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.

Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular Dystrophy
Tuesday 27 February 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Monday 12 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

More Wave Life Sciences Ltd News Articles

Global Developments (PK)

Mullen Automotive

NaturalShrimp (QB)

FBEC Worldwide (PK)

Tonner One World (PK)

Wanderport (PK)

Moon Equity (PK)

Branded Legacy (PK)

Virexit Technologies (PK)

NioCorp Developments

BlueFire Equipment (PK)

Impact Fusion (PK)

International Star (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions